nodes	percent_of_prediction	percent_of_DWPC	metapath
Pheniramine—Warfarin—Phenytoin—epilepsy syndrome	0.0792	0.0829	CrCrCtD
Pheniramine—Warfarin—Oxcarbazepine—epilepsy syndrome	0.0673	0.0705	CrCrCtD
Pheniramine—Phenprocoumon—Phenytoin—epilepsy syndrome	0.0668	0.07	CrCrCtD
Pheniramine—Modafinil—Fosphenytoin—epilepsy syndrome	0.0648	0.0679	CrCrCtD
Pheniramine—Cyclobenzaprine—Carbamazepine—epilepsy syndrome	0.0505	0.0529	CrCrCtD
Pheniramine—Doxepin—Oxcarbazepine—epilepsy syndrome	0.0494	0.0518	CrCrCtD
Pheniramine—Modafinil—Phenytoin—epilepsy syndrome	0.0444	0.0465	CrCrCtD
Pheniramine—Amitriptyline—Oxcarbazepine—epilepsy syndrome	0.0416	0.0436	CrCrCtD
Pheniramine—Modafinil—Carbamazepine—epilepsy syndrome	0.041	0.043	CrCrCtD
Pheniramine—Trimipramine—Carbamazepine—epilepsy syndrome	0.041	0.043	CrCrCtD
Pheniramine—Dimetacrine—Carbamazepine—epilepsy syndrome	0.0392	0.0411	CrCrCtD
Pheniramine—Trimipramine—Oxcarbazepine—epilepsy syndrome	0.0378	0.0396	CrCrCtD
Pheniramine—Modafinil—Oxcarbazepine—epilepsy syndrome	0.0378	0.0396	CrCrCtD
Pheniramine—Imipramine—Carbamazepine—epilepsy syndrome	0.0376	0.0394	CrCrCtD
Pheniramine—Dimetacrine—Oxcarbazepine—epilepsy syndrome	0.0361	0.0379	CrCrCtD
Pheniramine—Imipramine—Oxcarbazepine—epilepsy syndrome	0.0346	0.0363	CrCrCtD
Pheniramine—Alimemazine—Carbamazepine—epilepsy syndrome	0.0341	0.0358	CrCrCtD
Pheniramine—Benzphetamine—Phenytoin—epilepsy syndrome	0.0334	0.035	CrCrCtD
Pheniramine—Alimemazine—Oxcarbazepine—epilepsy syndrome	0.0315	0.033	CrCrCtD
Pheniramine—Diphenhydramine—Phenytoin—epilepsy syndrome	0.0297	0.0311	CrCrCtD
Pheniramine—Promazine—Carbamazepine—epilepsy syndrome	0.0294	0.0308	CrCrCtD
Pheniramine—Promazine—Oxcarbazepine—epilepsy syndrome	0.0271	0.0284	CrCrCtD
Pheniramine—Disopyramide—KCND2—epilepsy syndrome	0.000677	0.0655	CrCbGaD
Pheniramine—Methadyl Acetate—OPRM1—epilepsy syndrome	0.000314	0.0304	CrCbGaD
Pheniramine—Tropicamide—CHRM3—epilepsy syndrome	0.000302	0.0292	CrCbGaD
Pheniramine—Cyclopentolate—CHRM3—epilepsy syndrome	0.000292	0.0282	CrCbGaD
Pheniramine—Tropicamide—CHRM1—epilepsy syndrome	0.000281	0.0272	CrCbGaD
Pheniramine—Cyclopentolate—CHRM1—epilepsy syndrome	0.000272	0.0263	CrCbGaD
Pheniramine—Imipramine—KCND2—epilepsy syndrome	0.000253	0.0245	CrCbGaD
Pheniramine—Amitriptyline—KCND2—epilepsy syndrome	0.000252	0.0243	CrCbGaD
Pheniramine—Amitriptyline—KCNQ3—epilepsy syndrome	0.000234	0.0226	CrCbGaD
Pheniramine—Amitriptyline—KCNQ2—epilepsy syndrome	0.000234	0.0226	CrCbGaD
Pheniramine—Tropicamide—CHRM2—epilepsy syndrome	0.00023	0.0222	CrCbGaD
Pheniramine—Doxylamine—CHRM1—epilepsy syndrome	0.000229	0.0222	CrCbGaD
Pheniramine—Amitriptyline—NTRK2—epilepsy syndrome	0.000199	0.0192	CrCbGaD
Pheniramine—Orphenadrine—SCN9A—epilepsy syndrome	0.000194	0.0188	CrCbGaD
Pheniramine—Disopyramide—CHRM3—epilepsy syndrome	0.000186	0.018	CrCbGaD
Pheniramine—Tolterodine—CHRM3—epilepsy syndrome	0.000186	0.018	CrCbGaD
Pheniramine—Cyclopentolate—BCHE—epilepsy syndrome	0.000186	0.0179	CrCbGaD
Pheniramine—Orphenadrine—SCN4A—epilepsy syndrome	0.000179	0.0173	CrCbGaD
Pheniramine—Tolterodine—CHRM1—epilepsy syndrome	0.000174	0.0168	CrCbGaD
Pheniramine—Disopyramide—CHRM1—epilepsy syndrome	0.000174	0.0168	CrCbGaD
Pheniramine—Dimetindene—CHRM2—epilepsy syndrome	0.000164	0.0158	CrCbGaD
Pheniramine—Dextropropoxyphene—OPRD1—epilepsy syndrome	0.000154	0.0149	CrCbGaD
Pheniramine—Tolterodine—CHRM2—epilepsy syndrome	0.000142	0.0137	CrCbGaD
Pheniramine—Disopyramide—CHRM2—epilepsy syndrome	0.000142	0.0137	CrCbGaD
Pheniramine—Brompheniramine—CHRM3—epilepsy syndrome	0.000138	0.0134	CrCbGaD
Pheniramine—Levomethadyl Acetate—OPRM1—epilepsy syndrome	0.000137	0.0132	CrCbGaD
Pheniramine—Orphenadrine—SCN1A—epilepsy syndrome	0.000131	0.0126	CrCbGaD
Pheniramine—Brompheniramine—CHRM1—epilepsy syndrome	0.000129	0.0125	CrCbGaD
Pheniramine—Dextropropoxyphene—OPRM1—epilepsy syndrome	0.000118	0.0114	CrCbGaD
Pheniramine—Brompheniramine—CHRM2—epilepsy syndrome	0.000105	0.0102	CrCbGaD
Pheniramine—Methadone—OPRD1—epilepsy syndrome	0.000105	0.0101	CrCbGaD
Pheniramine—HRH1—GPCR ligand binding—CHRM3—epilepsy syndrome	9.45e-05	0.00267	CbGpPWpGaD
Pheniramine—HRH1—GPCRs, Class A Rhodopsin-like—BDKRB2—epilepsy syndrome	9.44e-05	0.00267	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—ACKR4—epilepsy syndrome	9.34e-05	0.00264	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—SSTR5—epilepsy syndrome	9.3e-05	0.00263	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—SSTR4—epilepsy syndrome	9.3e-05	0.00263	CbGpPWpGaD
Pheniramine—HRH1—GPCRs, Class A Rhodopsin-like—CNR1—epilepsy syndrome	9.27e-05	0.00262	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—CX3CR1—epilepsy syndrome	9.06e-05	0.00256	CbGpPWpGaD
Pheniramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR7—epilepsy syndrome	9.04e-05	0.00255	CbGpPWpGaD
Pheniramine—Doxepin—CHRM3—epilepsy syndrome	8.95e-05	0.00865	CrCbGaD
Pheniramine—HRH1—GPCR downstream signaling—CCR10—epilepsy syndrome	8.92e-05	0.00252	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—CX3CL1—epilepsy syndrome	8.89e-05	0.00251	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—CHRM2—epilepsy syndrome	8.89e-05	0.00251	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—BDKRB1—epilepsy syndrome	8.89e-05	0.00251	CbGpPWpGaD
Pheniramine—Mepyramine—CYP2D6—epilepsy syndrome	8.81e-05	0.00851	CrCbGaD
Pheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AVP—epilepsy syndrome	8.81e-05	0.00249	CbGpPWpGaD
Pheniramine—Tolterodine—CYP2C19—epilepsy syndrome	8.76e-05	0.00846	CrCbGaD
Pheniramine—HRH1—GPCR ligand binding—GABBR1—epilepsy syndrome	8.65e-05	0.00244	CbGpPWpGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR2—epilepsy syndrome	8.6e-05	0.00243	CbGpPWpGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—SST—epilepsy syndrome	8.6e-05	0.00243	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—SSTR4—epilepsy syndrome	8.45e-05	0.00239	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—SSTR5—epilepsy syndrome	8.45e-05	0.00239	CbGpPWpGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—epilepsy syndrome	8.42e-05	0.00238	CbGpPWpGaD
Pheniramine—Doxepin—CHRM1—epilepsy syndrome	8.35e-05	0.00807	CrCbGaD
Pheniramine—HRH1—GPCR ligand binding—HRH3—epilepsy syndrome	8.29e-05	0.00234	CbGpPWpGaD
Pheniramine—HRH1—G alpha (q) signalling events—HTR2A—epilepsy syndrome	8.19e-05	0.00231	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—OPRM1—epilepsy syndrome	8.16e-05	0.0023	CbGpPWpGaD
Pheniramine—Tripelennamine—CYP2D6—epilepsy syndrome	8.15e-05	0.00788	CrCbGaD
Pheniramine—Amitriptyline—OPRD1—epilepsy syndrome	8.14e-05	0.00787	CrCbGaD
Pheniramine—HRH1—Signaling by GPCR—CCR10—epilepsy syndrome	8.1e-05	0.00229	CbGpPWpGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL12—epilepsy syndrome	8.09e-05	0.00228	CbGpPWpGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—BDKRB2—epilepsy syndrome	8.09e-05	0.00228	CbGpPWpGaD
Pheniramine—Methadone—OPRM1—epilepsy syndrome	8.01e-05	0.00775	CrCbGaD
Pheniramine—Promazine—CHRM3—epilepsy syndrome	7.96e-05	0.00769	CrCbGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CNR1—epilepsy syndrome	7.94e-05	0.00224	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—GRM2—epilepsy syndrome	7.79e-05	0.0022	CbGpPWpGaD
Pheniramine—HRH1—G alpha (q) signalling events—AGT—epilepsy syndrome	7.77e-05	0.0022	CbGpPWpGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR7—epilepsy syndrome	7.75e-05	0.00219	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—CCR3—epilepsy syndrome	7.71e-05	0.00218	CbGpPWpGaD
Pheniramine—Warfarin—CYP2C19—epilepsy syndrome	7.62e-05	0.00736	CrCbGaD
Pheniramine—Carbinoxamine—CYP2C19—epilepsy syndrome	7.51e-05	0.00726	CrCbGaD
Pheniramine—HRH1—GPCR ligand binding—NPY—epilepsy syndrome	7.51e-05	0.00212	CbGpPWpGaD
Pheniramine—Benzphetamine—ADRA2A—epilepsy syndrome	7.48e-05	0.00723	CrCbGaD
Pheniramine—Promazine—CHRM1—epilepsy syndrome	7.42e-05	0.00717	CrCbGaD
Pheniramine—Cyclobenzaprine—HTR2A—epilepsy syndrome	7.41e-05	0.00716	CrCbGaD
Pheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—epilepsy syndrome	7.33e-05	0.00207	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—OXT—epilepsy syndrome	7.25e-05	0.00205	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—CRH—epilepsy syndrome	7.25e-05	0.00205	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—CXCL2—epilepsy syndrome	7.25e-05	0.00205	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—CCL3—epilepsy syndrome	7.25e-05	0.00205	CbGpPWpGaD
Pheniramine—Phenoxybenzamine—ADRA2A—epilepsy syndrome	7.15e-05	0.00691	CrCbGaD
Pheniramine—HRH1—IL-4 Signaling Pathway—AKT1—epilepsy syndrome	7.09e-05	0.002	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—GRM2—epilepsy syndrome	7.08e-05	0.002	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—SSTR3—epilepsy syndrome	7.05e-05	0.00199	CbGpPWpGaD
Pheniramine—Diphenhydramine—CHRM2—epilepsy syndrome	7.02e-05	0.00679	CrCbGaD
Pheniramine—Imipramine—CHRM3—epilepsy syndrome	6.97e-05	0.00673	CrCbGaD
Pheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—epilepsy syndrome	6.95e-05	0.00196	CbGpPWpGaD
Pheniramine—Amitriptyline—CHRM3—epilepsy syndrome	6.92e-05	0.00669	CrCbGaD
Pheniramine—Doxepin—CHRM2—epilepsy syndrome	6.82e-05	0.00659	CrCbGaD
Pheniramine—Cyclobenzaprine—CYP2D6—epilepsy syndrome	6.77e-05	0.00655	CrCbGaD
Pheniramine—HRH1—GPCR downstream signaling—CCR9—epilepsy syndrome	6.76e-05	0.00191	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—ARHGEF9—epilepsy syndrome	6.76e-05	0.00191	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—CCR8—epilepsy syndrome	6.76e-05	0.00191	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—SSTR1—epilepsy syndrome	6.76e-05	0.00191	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—NPY2R—epilepsy syndrome	6.76e-05	0.00191	CbGpPWpGaD
Pheniramine—Chlorphenamine—SLC6A4—epilepsy syndrome	6.74e-05	0.00651	CrCbGaD
Pheniramine—Orphenadrine—CHRM2—epilepsy syndrome	6.64e-05	0.00642	CrCbGaD
Pheniramine—HRH1—GPCR downstream signaling—GRM3—epilepsy syndrome	6.63e-05	0.00187	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—GRM4—epilepsy syndrome	6.63e-05	0.00187	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—SST—epilepsy syndrome	6.55e-05	0.00185	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—CCR2—epilepsy syndrome	6.55e-05	0.00185	CbGpPWpGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—AVP—epilepsy syndrome	6.52e-05	0.00184	CbGpPWpGaD
Pheniramine—Brompheniramine—CYP2C19—epilepsy syndrome	6.51e-05	0.00629	CrCbGaD
Pheniramine—HRH1—GPCR downstream signaling—SSTR2—epilepsy syndrome	6.51e-05	0.00184	CbGpPWpGaD
Pheniramine—Imipramine—CHRM1—epilepsy syndrome	6.5e-05	0.00628	CrCbGaD
Pheniramine—Tolterodine—CYP2D6—epilepsy syndrome	6.49e-05	0.00628	CrCbGaD
Pheniramine—HRH1—GPCRs, Class A Rhodopsin-like—CCR5—epilepsy syndrome	6.47e-05	0.00183	CbGpPWpGaD
Pheniramine—Amitriptyline—CHRM1—epilepsy syndrome	6.46e-05	0.00624	CrCbGaD
Pheniramine—HRH1—GPCR ligand binding—ADRA2A—epilepsy syndrome	6.41e-05	0.00181	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—SSTR3—epilepsy syndrome	6.4e-05	0.00181	CbGpPWpGaD
Pheniramine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6ST—epilepsy syndrome	6.4e-05	0.00181	CbGpPWpGaD
Pheniramine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—epilepsy syndrome	6.33e-05	0.00179	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—PRICKLE1—epilepsy syndrome	6.31e-05	0.00178	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—PRDM4—epilepsy syndrome	6.31e-05	0.00178	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—GRM8—epilepsy syndrome	6.28e-05	0.00177	CbGpPWpGaD
Pheniramine—Modafinil—CYP2C19—epilepsy syndrome	6.24e-05	0.00603	CrCbGaD
Pheniramine—Amitriptyline—OPRM1—epilepsy syndrome	6.23e-05	0.00602	CrCbGaD
Pheniramine—HRH1—GPCR ligand binding—CXCL12—epilepsy syndrome	6.16e-05	0.00174	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—BDKRB2—epilepsy syndrome	6.16e-05	0.00174	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—ARHGEF9—epilepsy syndrome	6.14e-05	0.00173	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—NPY2R—epilepsy syndrome	6.14e-05	0.00173	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—CCR9—epilepsy syndrome	6.14e-05	0.00173	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—SSTR1—epilepsy syndrome	6.14e-05	0.00173	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—CCR8—epilepsy syndrome	6.14e-05	0.00173	CbGpPWpGaD
Pheniramine—Trimipramine—ADRA2A—epilepsy syndrome	6.11e-05	0.0059	CrCbGaD
Pheniramine—Promazine—CHRM2—epilepsy syndrome	6.06e-05	0.00586	CrCbGaD
Pheniramine—HRH1—GPCR ligand binding—CNR1—epilepsy syndrome	6.05e-05	0.00171	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—GRM4—epilepsy syndrome	6.02e-05	0.0017	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—GRM3—epilepsy syndrome	6.02e-05	0.0017	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—OPRD1—epilepsy syndrome	5.99e-05	0.00169	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—SSTR2—epilepsy syndrome	5.91e-05	0.00167	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—HTR7—epilepsy syndrome	5.9e-05	0.00167	CbGpPWpGaD
Pheniramine—Doxepin—ADRA2A—epilepsy syndrome	5.82e-05	0.00562	CrCbGaD
Pheniramine—HRH1—GPCR downstream signaling—GRM1—epilepsy syndrome	5.75e-05	0.00162	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—CCR7—epilepsy syndrome	5.75e-05	0.00162	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—CHRM1—epilepsy syndrome	5.75e-05	0.00162	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—PDYN—epilepsy syndrome	5.75e-05	0.00162	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—GRM8—epilepsy syndrome	5.71e-05	0.00161	CbGpPWpGaD
Pheniramine—Atomoxetine—SLC6A4—epilepsy syndrome	5.66e-05	0.00547	CrCbGaD
Pheniramine—Carbinoxamine—CYP2D6—epilepsy syndrome	5.57e-05	0.00538	CrCbGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCR5—epilepsy syndrome	5.54e-05	0.00157	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—ACKR4—epilepsy syndrome	5.52e-05	0.00156	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—OPRD1—epilepsy syndrome	5.44e-05	0.00154	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—GNAO1—epilepsy syndrome	5.44e-05	0.00154	CbGpPWpGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—epilepsy syndrome	5.43e-05	0.00153	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—GAL—epilepsy syndrome	5.4e-05	0.00153	CbGpPWpGaD
Pheniramine—Atomoxetine—CYP2C19—epilepsy syndrome	5.37e-05	0.00519	CrCbGaD
Pheniramine—HRH1—GPCR downstream signaling—CHRM3—epilepsy syndrome	5.34e-05	0.00151	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—GRM5—epilepsy syndrome	5.34e-05	0.00151	CbGpPWpGaD
Pheniramine—Imipramine—CHRM2—epilepsy syndrome	5.31e-05	0.00513	CrCbGaD
Pheniramine—Imipramine—HTR7—epilepsy syndrome	5.28e-05	0.0051	CrCbGaD
Pheniramine—Amitriptyline—CHRM2—epilepsy syndrome	5.27e-05	0.0051	CrCbGaD
Pheniramine—Amitriptyline—HTR7—epilepsy syndrome	5.25e-05	0.00507	CrCbGaD
Pheniramine—HRH1—Signaling by GPCR—PDYN—epilepsy syndrome	5.22e-05	0.00147	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—GRM1—epilepsy syndrome	5.22e-05	0.00147	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—CHRM1—epilepsy syndrome	5.22e-05	0.00147	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—CCR7—epilepsy syndrome	5.22e-05	0.00147	CbGpPWpGaD
Pheniramine—Promazine—ADRA2A—epilepsy syndrome	5.17e-05	0.005	CrCbGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGT—epilepsy syndrome	5.15e-05	0.00145	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—BDKRB1—epilepsy syndrome	5.02e-05	0.00142	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—CHRM2—epilepsy syndrome	5.02e-05	0.00142	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—SSTR5—epilepsy syndrome	4.99e-05	0.00141	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—SSTR4—epilepsy syndrome	4.99e-05	0.00141	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—AVP—epilepsy syndrome	4.97e-05	0.0014	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—GAL—epilepsy syndrome	4.91e-05	0.00139	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—GABBR1—epilepsy syndrome	4.89e-05	0.00138	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—CHRM3—epilepsy syndrome	4.85e-05	0.00137	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—GRM5—epilepsy syndrome	4.85e-05	0.00137	CbGpPWpGaD
Pheniramine—Brompheniramine—CYP2D6—epilepsy syndrome	4.83e-05	0.00466	CrCbGaD
Pheniramine—HRH1—Signaling Pathways—CCR10—epilepsy syndrome	4.78e-05	0.00135	CbGpPWpGaD
Pheniramine—Phenprocoumon—ALB—epilepsy syndrome	4.76e-05	0.0046	CrCbGaD
Pheniramine—Chlorphenamine—CYP2D6—epilepsy syndrome	4.74e-05	0.00458	CrCbGaD
Pheniramine—HRH1—GPCR downstream signaling—HRH3—epilepsy syndrome	4.68e-05	0.00132	CbGpPWpGaD
Pheniramine—Trimipramine—SLC6A4—epilepsy syndrome	4.66e-05	0.0045	CrCbGaD
Pheniramine—HRH1—Signaling by GPCR—CX3CR1—epilepsy syndrome	4.65e-05	0.00131	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—OPRM1—epilepsy syndrome	4.61e-05	0.0013	CbGpPWpGaD
Pheniramine—Dextropropoxyphene—CYP2D6—epilepsy syndrome	4.57e-05	0.00442	CrCbGaD
Pheniramine—HRH1—Signaling by GPCR—CHRM2—epilepsy syndrome	4.56e-05	0.00129	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—BDKRB1—epilepsy syndrome	4.56e-05	0.00129	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—CX3CL1—epilepsy syndrome	4.56e-05	0.00129	CbGpPWpGaD
Pheniramine—Amitriptyline—ADRA2A—epilepsy syndrome	4.5e-05	0.00435	CrCbGaD
Pheniramine—Doxepin—SLC6A4—epilepsy syndrome	4.44e-05	0.00429	CrCbGaD
Pheniramine—HRH1—Signaling by GPCR—GABBR1—epilepsy syndrome	4.44e-05	0.00125	CbGpPWpGaD
Pheniramine—Trimipramine—CYP2C19—epilepsy syndrome	4.42e-05	0.00427	CrCbGaD
Pheniramine—HRH1—GPCR downstream signaling—CCR3—epilepsy syndrome	4.36e-05	0.00123	CbGpPWpGaD
Pheniramine—Atomoxetine—HTR2A—epilepsy syndrome	4.35e-05	0.00421	CrCbGaD
Pheniramine—Diphenhydramine—CYP2C19—epilepsy syndrome	4.34e-05	0.00419	CrCbGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—epilepsy syndrome	4.33e-05	0.00122	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—HRH3—epilepsy syndrome	4.25e-05	0.0012	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—NPY—epilepsy syndrome	4.24e-05	0.0012	CbGpPWpGaD
Pheniramine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—epilepsy syndrome	4.24e-05	0.0012	CbGpPWpGaD
Pheniramine—Warfarin—ALB—epilepsy syndrome	4.23e-05	0.00408	CrCbGaD
Pheniramine—HRH1—GPCR ligand binding—CCR5—epilepsy syndrome	4.22e-05	0.00119	CbGpPWpGaD
Pheniramine—Doxepin—CYP2C19—epilepsy syndrome	4.21e-05	0.00407	CrCbGaD
Pheniramine—HRH1—Signaling by GPCR—OPRM1—epilepsy syndrome	4.19e-05	0.00118	CbGpPWpGaD
Pheniramine—Methadone—CYP2C19—epilepsy syndrome	4.19e-05	0.00405	CrCbGaD
Pheniramine—HRH1—Signaling Pathways—GRM2—epilepsy syndrome	4.18e-05	0.00118	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—HTR2A—epilepsy syndrome	4.13e-05	0.00117	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—OXT—epilepsy syndrome	4.09e-05	0.00116	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—CRH—epilepsy syndrome	4.09e-05	0.00116	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—CXCL2—epilepsy syndrome	4.09e-05	0.00116	CbGpPWpGaD
Pheniramine—Atomoxetine—CYP2D6—epilepsy syndrome	3.98e-05	0.00385	CrCbGaD
Pheniramine—HRH1—Signaling by GPCR—CCR3—epilepsy syndrome	3.95e-05	0.00112	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—AGT—epilepsy syndrome	3.92e-05	0.00111	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—NPY—epilepsy syndrome	3.85e-05	0.00109	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—SSTR3—epilepsy syndrome	3.78e-05	0.00107	CbGpPWpGaD
Pheniramine—Promazine—CYP2C19—epilepsy syndrome	3.74e-05	0.00361	CrCbGaD
Pheniramine—HRH1—Signaling by GPCR—CRH—epilepsy syndrome	3.72e-05	0.00105	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—CCL3—epilepsy syndrome	3.72e-05	0.00105	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—CXCL2—epilepsy syndrome	3.72e-05	0.00105	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—OXT—epilepsy syndrome	3.72e-05	0.00105	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—SST—epilepsy syndrome	3.7e-05	0.00105	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—CCR2—epilepsy syndrome	3.7e-05	0.00105	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—ST3GAL3—epilepsy syndrome	3.7e-05	0.00105	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—ARHGEF9—epilepsy syndrome	3.63e-05	0.00102	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—CCR8—epilepsy syndrome	3.63e-05	0.00102	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—CCR9—epilepsy syndrome	3.63e-05	0.00102	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—NPY2R—epilepsy syndrome	3.63e-05	0.00102	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—SSTR1—epilepsy syndrome	3.63e-05	0.00102	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—ADRA2A—epilepsy syndrome	3.62e-05	0.00102	CbGpPWpGaD
Pheniramine—Trimipramine—HTR2A—epilepsy syndrome	3.58e-05	0.00346	CrCbGaD
Pheniramine—HRH1—Signaling Pathways—GRM4—epilepsy syndrome	3.56e-05	0.001	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—GRM3—epilepsy syndrome	3.56e-05	0.001	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—DUSP4—epilepsy syndrome	3.49e-05	0.000986	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—SSTR2—epilepsy syndrome	3.49e-05	0.000986	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—CXCL12—epilepsy syndrome	3.48e-05	0.000983	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—BDKRB2—epilepsy syndrome	3.48e-05	0.000983	CbGpPWpGaD
Pheniramine—Imipramine—SLC6A4—epilepsy syndrome	3.45e-05	0.00334	CrCbGaD
Pheniramine—Amitriptyline—SLC6A4—epilepsy syndrome	3.43e-05	0.00332	CrCbGaD
Pheniramine—HRH1—GPCR downstream signaling—CNR1—epilepsy syndrome	3.42e-05	0.000965	CbGpPWpGaD
Pheniramine—Doxepin—HTR2A—epilepsy syndrome	3.41e-05	0.0033	CrCbGaD
Pheniramine—HRH1—GPCR downstream signaling—PLCB1—epilepsy syndrome	3.41e-05	0.000962	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—GRM8—epilepsy syndrome	3.37e-05	0.000952	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—PGF—epilepsy syndrome	3.37e-05	0.000952	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—CCR2—epilepsy syndrome	3.36e-05	0.00095	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—SST—epilepsy syndrome	3.36e-05	0.00095	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—HTR7—epilepsy syndrome	3.33e-05	0.000942	CbGpPWpGaD
Pheniramine—HRH1—GPCR ligand binding—POMC—epilepsy syndrome	3.3e-05	0.000932	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—ADRA2A—epilepsy syndrome	3.29e-05	0.000929	CbGpPWpGaD
Pheniramine—Imipramine—CYP2C19—epilepsy syndrome	3.27e-05	0.00316	CrCbGaD
Pheniramine—Trimipramine—CYP2D6—epilepsy syndrome	3.27e-05	0.00316	CrCbGaD
Pheniramine—Amitriptyline—CYP2C19—epilepsy syndrome	3.25e-05	0.00315	CrCbGaD
Pheniramine—HRH1—GPCR ligand binding—CCL2—epilepsy syndrome	3.23e-05	0.000912	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—OPRD1—epilepsy syndrome	3.22e-05	0.000908	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—GNAO1—epilepsy syndrome	3.22e-05	0.000908	CbGpPWpGaD
Pheniramine—Diphenhydramine—CYP2D6—epilepsy syndrome	3.21e-05	0.00311	CrCbGaD
Pheniramine—HRH1—GPCR downstream signaling—AKT3—epilepsy syndrome	3.18e-05	0.000897	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—BDKRB2—epilepsy syndrome	3.16e-05	0.000893	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—CXCL12—epilepsy syndrome	3.16e-05	0.000893	CbGpPWpGaD
Pheniramine—Doxepin—CYP2D6—epilepsy syndrome	3.12e-05	0.00302	CrCbGaD
Pheniramine—HRH1—Signaling by GPCR—CNR1—epilepsy syndrome	3.1e-05	0.000876	CbGpPWpGaD
Pheniramine—Methadone—CYP2D6—epilepsy syndrome	3.1e-05	0.003	CrCbGaD
Pheniramine—HRH1—Signaling by GPCR—PLCB1—epilepsy syndrome	3.09e-05	0.000873	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—GRM1—epilepsy syndrome	3.08e-05	0.000871	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—CHRM1—epilepsy syndrome	3.08e-05	0.000871	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—CCR7—epilepsy syndrome	3.08e-05	0.000871	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—PDYN—epilepsy syndrome	3.08e-05	0.000871	CbGpPWpGaD
Pheniramine—Promazine—HTR2A—epilepsy syndrome	3.03e-05	0.00293	CrCbGaD
Pheniramine—HRH1—Signaling by GPCR—HTR7—epilepsy syndrome	3.03e-05	0.000855	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—HBEGF—epilepsy syndrome	2.94e-05	0.00083	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—CDC42—epilepsy syndrome	2.9e-05	0.000819	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—GFAP—epilepsy syndrome	2.9e-05	0.000819	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—GAL—epilepsy syndrome	2.9e-05	0.000819	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—AKT3—epilepsy syndrome	2.89e-05	0.000815	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—GRM5—epilepsy syndrome	2.87e-05	0.000809	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—CASP2—epilepsy syndrome	2.87e-05	0.000809	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—CHRM3—epilepsy syndrome	2.87e-05	0.000809	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—AVP—epilepsy syndrome	2.81e-05	0.000793	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—CX3CR1—epilepsy syndrome	2.75e-05	0.000776	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—CX3CL1—epilepsy syndrome	2.69e-05	0.000761	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—BDKRB1—epilepsy syndrome	2.69e-05	0.000761	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—CHRM2—epilepsy syndrome	2.69e-05	0.000761	CbGpPWpGaD
Pheniramine—Imipramine—HTR2A—epilepsy syndrome	2.65e-05	0.00257	CrCbGaD
Pheniramine—Amitriptyline—HTR2A—epilepsy syndrome	2.64e-05	0.00255	CrCbGaD
Pheniramine—HRH1—Signaling by GPCR—CDC42—epilepsy syndrome	2.63e-05	0.000743	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—GABBR1—epilepsy syndrome	2.62e-05	0.00074	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—AVP—epilepsy syndrome	2.55e-05	0.00072	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—HRH3—epilepsy syndrome	2.51e-05	0.00071	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—OPRM1—epilepsy syndrome	2.47e-05	0.000699	CbGpPWpGaD
Pheniramine—Imipramine—CYP2D6—epilepsy syndrome	2.43e-05	0.00235	CrCbGaD
Pheniramine—Amitriptyline—CYP2D6—epilepsy syndrome	2.41e-05	0.00233	CrCbGaD
Pheniramine—HRH1—GPCR downstream signaling—CCR5—epilepsy syndrome	2.39e-05	0.000674	CbGpPWpGaD
Pheniramine—Trimipramine—ABCB1—epilepsy syndrome	2.34e-05	0.00226	CrCbGaD
Pheniramine—HRH1—Signaling Pathways—CCR3—epilepsy syndrome	2.34e-05	0.00066	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—HTR2A—epilepsy syndrome	2.34e-05	0.000659	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—ATP2A2—epilepsy syndrome	2.28e-05	0.000643	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—NPY—epilepsy syndrome	2.28e-05	0.000643	CbGpPWpGaD
Pheniramine—Doxepin—ABCB1—epilepsy syndrome	2.23e-05	0.00215	CrCbGaD
Pheniramine—Methadone—ABCB1—epilepsy syndrome	2.22e-05	0.00214	CrCbGaD
Pheniramine—HRH1—GPCR downstream signaling—AGT—epilepsy syndrome	2.22e-05	0.000626	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—HSPB1—epilepsy syndrome	2.2e-05	0.00062	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—CRH—epilepsy syndrome	2.2e-05	0.00062	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—OXT—epilepsy syndrome	2.2e-05	0.00062	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—CCL3—epilepsy syndrome	2.2e-05	0.00062	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—CXCL2—epilepsy syndrome	2.2e-05	0.00062	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—CCR5—epilepsy syndrome	2.17e-05	0.000612	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—HTR2A—epilepsy syndrome	2.12e-05	0.000599	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—PRKCB—epilepsy syndrome	2.05e-05	0.000578	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—TSC1—epilepsy syndrome	2.04e-05	0.000577	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—PTK2B—epilepsy syndrome	2.04e-05	0.000577	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—AGT—epilepsy syndrome	2.01e-05	0.000568	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—SST—epilepsy syndrome	1.99e-05	0.000561	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—CCR2—epilepsy syndrome	1.99e-05	0.000561	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—NTRK2—epilepsy syndrome	1.99e-05	0.000561	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—DUSP6—epilepsy syndrome	1.97e-05	0.000556	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—ADRA2A—epilepsy syndrome	1.94e-05	0.000549	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—PLAT—epilepsy syndrome	1.94e-05	0.000547	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—BDKRB2—epilepsy syndrome	1.87e-05	0.000527	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—CXCL12—epilepsy syndrome	1.87e-05	0.000527	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—POMC—epilepsy syndrome	1.86e-05	0.000527	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—PRKCB—epilepsy syndrome	1.86e-05	0.000525	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—IL6ST—epilepsy syndrome	1.85e-05	0.000523	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—JUNB—epilepsy syndrome	1.83e-05	0.000518	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—CNR1—epilepsy syndrome	1.83e-05	0.000518	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—PLCB1—epilepsy syndrome	1.83e-05	0.000516	CbGpPWpGaD
Pheniramine—Amitriptyline—ALB—epilepsy syndrome	1.81e-05	0.00174	CrCbGaD
Pheniramine—HRH1—Signaling Pathways—HTR7—epilepsy syndrome	1.79e-05	0.000505	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—HBEGF—epilepsy syndrome	1.74e-05	0.00049	CbGpPWpGaD
Pheniramine—Imipramine—ABCB1—epilepsy syndrome	1.73e-05	0.00168	CrCbGaD
Pheniramine—Amitriptyline—ABCB1—epilepsy syndrome	1.72e-05	0.00167	CrCbGaD
Pheniramine—HRH1—Signaling Pathways—AKT3—epilepsy syndrome	1.7e-05	0.000481	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—POMC—epilepsy syndrome	1.69e-05	0.000478	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—ADAM10—epilepsy syndrome	1.66e-05	0.00047	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—CCL2—epilepsy syndrome	1.66e-05	0.000468	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—S100B—epilepsy syndrome	1.57e-05	0.000445	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—SOCS3—epilepsy syndrome	1.56e-05	0.00044	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—CDC42—epilepsy syndrome	1.56e-05	0.000439	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—AVP—epilepsy syndrome	1.51e-05	0.000425	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—HES1—epilepsy syndrome	1.42e-05	0.000402	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—FYN—epilepsy syndrome	1.38e-05	0.000391	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—H2AFX—epilepsy syndrome	1.38e-05	0.00039	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—MEF2C—epilepsy syndrome	1.38e-05	0.000389	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.33e-05	0.000376	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—NGF—epilepsy syndrome	1.32e-05	0.000372	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—CCR5—epilepsy syndrome	1.28e-05	0.000361	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—HTR2A—epilepsy syndrome	1.25e-05	0.000354	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—TSC2—epilepsy syndrome	1.19e-05	0.000336	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—AGT—epilepsy syndrome	1.19e-05	0.000336	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—APOE—epilepsy syndrome	1.16e-05	0.000329	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—KDR—epilepsy syndrome	1.14e-05	0.000322	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	1.1e-05	0.00031	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	1.09e-05	0.000309	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—POMC—epilepsy syndrome	1e-05	0.000283	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	9.79e-06	0.000276	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	8.85e-06	0.00025	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—RELA—epilepsy syndrome	8.21e-06	0.000232	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	8.05e-06	0.000227	CbGpPWpGaD
Pheniramine—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	7.48e-06	0.000211	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	7.41e-06	0.000209	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—JUN—epilepsy syndrome	7.19e-06	0.000203	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	7e-06	0.000198	CbGpPWpGaD
Pheniramine—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	6.79e-06	0.000192	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—SRC—epilepsy syndrome	6.45e-06	0.000182	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	6.29e-06	0.000178	CbGpPWpGaD
Pheniramine—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	4.01e-06	0.000113	CbGpPWpGaD
